// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Ct derived fractional flow reserve outcomes from a district general hospital led service

Yande Kasolo - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes

Jian Yeo - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Cardiac mri global longitudinal strain has greater sensitivity than ejection fraction to predict heart failure in breast cancer patients receiving trastuzumab

Jian Yeo - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Trastuzumab

Invasive validation of pressure volume loops derived from cardiovascular magnetic resonance imaging and brachial blood pressure in heart failure patients

Per Arvidsson - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Effects of a low energy meal replacement programme on reverse cardiac remodelling in asymptomatic people with type 2 diabetes a comparison between south asians and white europeans

Lavanya Athithan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

N/A

Multi system investigation of covid 19 illness

Kenneth Mangion - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Common reasons of rejected transthoracic echocardiogram requests in a tertiary referral hospital

See Wei Lim - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparing image quality and reporting times for scar identification between 2d and 3d sequences in cardiac magnetic resonance imaging

Nikesh Jathanna - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Triage of cardiac imaging testing did not impact patient outcomes in a large cardiac network during the covid 19 pandemic

Abhishek Joshi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Feasibility of cardiovascular magnetic resonance surveillance of LV function in women with breast cancer treated with trastuzumab

lydia bevis - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Cardiotoxicity

Trastuzumab

The use and efficacy of ffr ct a real world multi centre audit of clinical data and cost analysis

Sandeep Hothi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Gestational diabetes preeclampsia and the maternal heart

Sharmaine Thirunavukarasu - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Gestational Diabetes

N/A

Coronary artery calcification on non gated non cardiac ct has prognostic and treatment implications regardless of age

John Graby - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Complex calcified coronary artery lesions

N/A

Outcomes of a nationwide cardiac screening programme in young individuals

Hamish MacLachlan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association between age troponin level and mortality in patients presenting to hospital with acute pulmonary embolism nihr health informatics collaborative trop pe study

Amit Kaura - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary embolism

N/A

Association between troponin and mortality in acute stroke nihr health informatics collaborative trop stroke study

Amit Kaura - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Impact of sex on the incidence of atrial fibrillation in the community a systematic review and meta analysis

Omar Ali - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Predicting outcomes in chronic coronary syndromes with high sensitivity cardiac troponin

Ryan Wereski - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The risk of sex based inequality with contemporary esc 2019 chronic coronary syndrome guidelines compared with nice guidelines

Saad Fyyaz - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

High sensitivity troponin is a biomarker of medium term mortality in 20 000 consecutive hospital patients undergoing a blood test for any reason

Jonathan Hinton - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved